SIA
NNVC icon

Stancorp Investment Advisers’s NanoViricides NNVC Stock Holding History

Stancorp Investment Advisers’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$45K Buy
1,000
+100
+11% +$5.33K 0.02% 289
2014
Q4 		$49K Buy
+900
New +$59.6K 0.02% 263

Other funds holding NNVC

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Stancorp Investment Advisers's NNVC Position: Q1 2015 in Review

Stancorp Investment Advisers increased its NanoViricides (NNVC) stake by 11% in Q1 2015, buying an estimated $5.33K and bringing the position to 1,000 shares worth $45K. The position accounts for 0.02% of the portfolio, ranked #289.

Stancorp Investment Advisers first reported a position in NNVC in Q4 2014 and has held it in 2 quarters since. The position peaked at $49K in Q4 2014. 58 funds tracked by Wall St. Rank hold NNVC as of Q1 2015.

  • Stancorp Investment Advisers held 1,000 shares of NanoViricides worth $45K as of Q1 2015.
  • Stancorp Investment Advisers bought 100 NanoViricides shares in Q1 2015, an estimated $5.33K.
  • NanoViricides made up 0.02% of Stancorp Investment Advisers's portfolio in Q1 2015, its #289 holding.
  • Stancorp Investment Advisers first reported a position in NanoViricides in Q4 2014 and has held it in 2 quarters since.
  • Stancorp Investment Advisers's NanoViricides position peaked at $49K in Q4 2014.
  • 58 funds tracked by Wall St. Rank held NanoViricides as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.